aspartylglycosaminuria

(redirected from Aspartylglucosaminuria)
Also found in: Acronyms, Wikipedia.

as·par·tyl·gly·cos·a·mi·nu·ri·a

(as-par'til-glī-kō'să-min-yū'rē-ă), [MIM*208400]
A lysosomal disorder caused by deficiency of aspartoglucosaminidase, resulting in accumulation of aspartylglycosamine in the urine and spinal fluid; characterized by symptoms usually in the first few months of life, with recurrent infections and diarrhea; mental retardation, seizures, coarse facial features, and skeletal abnormalities become evident by adolescence. Autosomal recessive inheritance, caused by mutation in the aspartoglucosaminidase gene (AGA) on 4q.
Farlex Partner Medical Dictionary © Farlex 2012

aspartylglycosaminuria

A disease due to deficiency of the enzyme aspartylglycosaminidase which splits acetylglucosamine from the polypeptide chain of glycoproteins. Aspartylglucosamine is excreted in large quantities in the urine. Affected children are short, with coarse features, cataracts, over-mobile joints and mental retardation. Most of the reported cases have been in Finland.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

as·par·tyl·gly·cos·a·mi·nu·ri·a

(as-par'til-glī-kō'să-min-yū'rē-ă) [MIM*208400]
A lysosomal disorder caused by deficiency of aspartoglucosaminidase; involves recurrent infections and diarrhea; mental retardation, seizures, coarse facial features, and skeletal abnormalities that become evident by adolescence.
Medical Dictionary for the Dental Professions © Farlex 2012
Mentioned in ?
References in periodicals archive ?
[3] Nonstandard abbreviations: LSD, lysosomal storage disease; FOS, free oligosaccharides; MS, mass spectrometry; AGU, aspartylglucosaminuria; ANTS, 2-aminonaphthalene trisulfone; GlcNAc, N-acetylglucosamine; MALDI-TOF/TOF, MALDI-time-of-flight/time-of-flight; DHB, 2,5-dihydroxybenzoic acid; TFA, trifluoroacetic acid; Asn, asparagine; ML, mucolipidosis; GNPT, GlcNAc phosphotransferase.
Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland.
Urinary oligosaccharides Disease Sialyl-oligosaccharides Sialidose I Sialidose II Galactosialidosis Galactosyl-oligosaccharides GMI gangliosidosis Morquio type B Glucosaminyl-oligosaccharides Sandhorf disease Fucosyl-oligosaccharides Fucosidosis R-GIcNAc([beta]1-N)Asn (a) Aspartylglucosaminuria [alpha]-Mannosyl-oligosaccharides [alpha]-Mannosidosis with a GIcNAc residue at the reducing end Man([beta]1-4)GIcNAc R-Mannosidosis (a) R, oligosaccharide group.
Finnishtype aspartylglucosaminuria detected by oligonucleotide ligation assay.
It should also be mentioned that other glycoprotein degradation disorders, such as aspartylglucosaminuria or Schindler disease (6, 21), are characterized by abnormal excretion of glycopeptides and cannot be identified by this technique.